Categories: World

BRIEF-Jiangsu Nhwa: NMPA Approves NH302 Injection, NH130 Citrate Tablets Clinical Trials

Published by
TDG Syndication

Aug 18 (Reuters) – Jiangsu Nhwa Pharmaceutical Co Ltd : * SAYS NMPA APPROVES CLINICAL TRIALS OF NH302 INJECTION, NH130 CITRATE TABLETS Source text Source text Further company coverage: (Reporting by

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)

TDG Syndication
Published by TDG Syndication